{"name":"Immunophotonics, Inc.","slug":"immunophotonics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNVHdLOUpTX2x1a2FoeVVnU1BQTWVlcS1wZWd3ZXM4a1hNclNremVCMi1uY1lhckhkbmNIdXQwbzhzVzE0aC1QME1HNWFYVWxoUlh6c3VaQlpPSG5QOFRyc3h3Y04tYlZuazhtdnZmU0sxR2dlN1F5SHhLZnpNZjdQZFlvN0c2dzlFWW5EVFcxUm94NXFua0pVakUySDFLdmVqaDFlajYxWm1RUQ?oc=5","date":"2025-08-20","type":"pipeline","source":"BioSpace","summary":"5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development - BioSpace","headline":"5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNaXJHcGJMaFVYMGNWOTJSa21wNFdQSi1ZRkpZN2F6Z2ZVRGRNbWJyTm4zdTdjdnNjcWNFQVVCQTZEeElSNmwxQlJUem1LNlRTRElfZzdlb2RBZE01X1ZTLWpSZG94bW1rMF93WlExaEcxcFZaQU1ZWTJCSlI4TWM4U3kzbTg5S3BkUnFfalZaOEs0d1h1MzJIU1IzSHhnbGtHQVVwTjduWWhxTWNYRDVROFpTdW9jdC0wekQySFNSMU1oQXVWV1pHUWxZMjZEM1pGYkRoRl9RcS1ZT3VoTWVjY2NiRHlQWjJoczFCYUxjVDZfTFNRakpuUFUwS05JSEdNOEhoRER1ZTcyamx3SF9jTmFB?oc=5","date":"2025-07-31","type":"trial","source":"PR Newswire","summary":"Immunophotonics Completes Treatment of Last Patient in INJECTABL-1 Phase 1b/2a Clinical Trial of IP-001 for Advanced Solid Tumors - PR Newswire","headline":"Immunophotonics Completes Treatment of Last Patient in INJECTABL-1 Phase 1b/2a Clinical Trial of IP-001 for Advanced Sol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNSFd6NG5OWEk4al83WU10YjU5M0NlSDNWb3VnZjVtSDNEYXpuMEJHUUhxZW9XYXpmQ18zYkVlblprTjA1cUdjTE8xUFVDUGlKRzZ3RkZkNlRkWWZydmlnYzhsejNmODRWUFA0QVRITTJoZmtlMVc2QTJ0dVdoR0Y1clJkLTVCNGJzYVFXR1VOeWFsbkprN01UOGNNcmpDX01hZ2JZQ3V0NA?oc=5","date":"2022-10-14","type":"deal","source":"Smart Business Dealmakers","summary":"Immunophotonics Makes Strides in Cancer Research - Smart Business Dealmakers","headline":"Immunophotonics Makes Strides in Cancer Research","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}